Navigation Links
Tuberculosis strain in indigenous communities linked to Canadian fur trade
Date:4/18/2011

Researchers have found that a strain of tuberculosis (TB) responsible for devastating some isolated Aboriginal populations in Canada was first introduced to these communities by French Canadian fur traders between 1710 and 1870.

The team has found a traceable link between the fur trade routes and modern day patterns of tuberculosis. Wendy Wobeser, a professor with Queen's Division of Infectious Diseases, is the member of this research team who originally identified the presence of this particular strain of TB in remote Aboriginal communities in Saskatchewan. Through her later work in northwestern Ontario with the Sioux Lookout First Nations Health Authority the link was made to the mode of introduction of the strain to remote First Nations communities.

"This research represents a level of thinking never applied to tuberculosis epidemiology in this country or elsewhere," says Dr. Wobeser. "Examining the migration and epidemiological traits of this disease could help researchers explain why it is proving so difficult to eradicate."

The researchers have hypothesized that social distance between indigenous peoples and various migrant groups contributed to this historical phenomenon. While the fur trade era was characterized by close social contact, intermarriage and trading collaborations, later waves of migrants who moved across Canada remained more socially and geographically isolated from indigenous peoples.

In order to better understand the migratory dynamics of TB in Canada, the researchers focused on a particular bacterial lineage. They connected the dispersal of this particular strain of TB to an estimated 5,419 individuals who migrated across Canada from Quebec during the fur trade era.

Despite the fact that later waves of immigration brought millions of individuals to Canada from global regions of high TB incidence, the particular tubercular strain introduced by the early fur traders remains the dominant stra
'/>"/>

Contact: Christina Archibald
christina.archibald@queensu.ca
61-353-332-877
Queen's University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gene with probable role in human susceptibility to pulmonary tuberculosis identified
2. Proteomics study yields clues as to how tuberculosis might be thwarting the immune system
3. Forsyth scientist receives major grant to support rapid, accurate, affordable test for tuberculosis
4. In India: A search for more effective tuberculosis drugs
5. Iowa State University researcher uncovers potential key to curing tuberculosis
6. Scientists take step toward simple and portable tuberculosis tests for developing world
7. Immune evasion common in many viruses, bacteria and parasites is uncommon in M. tuberculosis
8. Genome of bacteria responsible for tuberculosis of olive tree sequenced
9. Bodys own proteins may lead the way in global fight against tuberculosis
10. Study finds possible persistence switch for tuberculosis
11. New tool in the fight against tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and Markets( ... "Natural Language Processing Market by Type (Rule-Based, ... & Image Recognition) - Worldwide Forecast to 2020" ... key vendors occupying the market are 3M, Apple, ... NetBase Solutions, SAS Institute Inc., Verint Systems among ...
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... the spread of deadly strains of avian flu such ... and Warwick have found. The research shows that even ... the disease is likely to spread unless almost all ... in Nature journal, is the first to quantify how ...
... comprehensive scientific study of tiger habitats ever done finds that ... they were thought to a decade ago. The tigers ... , This landmark study, commissioned by the National ... by some of the world's leading tiger scientists at World ...
... of researchers led by Prof. Irun Cohen of the ... mechanism of a vaccine for Type 1 diabetes. The ... vaccine, which is currently in advanced stages of clinical ... which the immune system mistakenly attacks the body's own ...
Cached Biology News:Bird flu study highlights need to vaccinate flocks effectively 2New tiger report release: Tiger habitat down from just a decade ago 2The molecular mechanism of a diabetes vaccine revealed 2
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/29/2015)... 2015 Sanofi, un leader ... résultats pour le premier semestre 2015. Le Directeur ... Visionner l,interview vidéo et lire la ... Au sommaire de l,interview :  ... croissance - Diabète - ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation (NYSE: ... providers of post-acute healthcare services, offering both facility-based ... of operations for the second quarter ended June 30, ... characterized by strong volume growth in both segments ... said Jay Grinney, President and Chief Executive Officer ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15
... Sept. 26 Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ... in New York City on Thursday, October 4, 2007,from ... Westin New York at Times,Square, on 270 West 43rd ... C. Quay, M.D., Ph.D., Chairman, President and,Chief Executive Officer ...
... CLEARWATER, Fla., Sept. 26 Advanced Bio-Technologies,Inc (ABT) is ... have been purchased by HealthEdge Investment Partners of Tampa,FL. ... CEO, commented, "This is a new stage,in the exciting ... up,sales and marketing in the USA, build the necessary ...
... Finance Corporation,one of the nation,s leading providers of ... it has finalized a $7 million secured loan,agreement ... be used,to support Othera,s goal to become a ... for,ophthalmology, oncology and inflammatory disease. "This is ...
Cached Biology Technology:Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL 2Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals 2
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Ms anti-Cyclophilin D...
... Intended to qualitatively ... in formalin-fixed, paraffin-embedded (FFPE) ... spreads, and cell preparations, ... Hybridization (CISH). Fluorescent In ...
Mouse GM CSF Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: